欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/3869/002
药品名称TAPTIQOM 15 Mikrogramm/ml + 5 mg/ml Augentropfen, Lösung
活性成分
    • Tafluprost 15.0 µg
    • Timolol maleate 6.84 mg
剂型Eye drops, solution
上市许可持有人Santen Oy Niittyhaankatu 20 FIN-33720 TAMPERE
参考成员国 - 产品名称Germany (DE)
TAPTIQOM 15 Mikrogramm/ml + 5 mg/ml Augentropfen, Lösung
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Taptiqom
    • Netherlands (NL)
      Taptiqom 15 microgram/ml + 5 mg/ml oogdruppels, oplossing
    • Luxembourg (LU)
    • Iceland (IS)
      Taptiqom 15 microg/ml + 5 mg/ml Augndropar, lausn
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Taptiqom 15 Mikrogramm/ml + 5 mg/ml Augentropfen, Lösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Taptoiqom
    • Finland (FI)
    • Poland (PL)
      TAPTIQOM Multi
    • Latvia (LV)
      Taptiqom 15 mikrogrami/5 mg/ml acu pilieni, šķīdums
    • Lithuania (LT)
      TAPTIQOM 15 mikrogramų/5 mg/ml akių lašai (tirpalas)
    • Estonia (EE)
      TAPTIQOM SINE
    • Hungary (HU)
    • Bulgaria (BG)
      Taptiqom
    • Cyprus (CY)
    • Czechia (CZ)
      TAPTIQOM
    • Slovakia (SK)
      TAPTIQOM 15 mikrogramov/ml + 5 mg/ml očné roztokové kvapky
    • Slovenia (SI)
    • Croatia (HR)
许可日期2020/07/31
最近更新日期2024/12/23
药物ATC编码
    • S01ED51 timolol, combinations
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase